Diabetes Care Devices: Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016

Introduction

GlobalData’s new report, “Diabetes Care Devices - Emerging Countries Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016” provides key data, information and analysis on the diabetes care devices market in China and India. The report provides market landscape, competitive landscape and market trends information the diabetes care devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Key segments covered include Glucose Monitoring and Insulin Delivery.
- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within the diabetes care devices market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Bayer HealthCare AG, Abbott Laboratories, Medtronic, Inc., Becton, Dickinson and Company and Novo Nordisk A/S.

Highlights

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the diabetes care devices market in China and India.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next being thing in the diabetes care devices market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the diabetes care devices market and the factors shaping it.

Report Highlights
F. Hoffmann-La Roche Ltd
LifeScan (Johnson & Johnson)
Bayer Healthcare
Abbott Laboratories
Becton, Dickinson and Company
Medtronic
Novo Nordisk
Hangzhou Yikang Biotech Co., Ltd.
Biocare
Zhejiang Guoguang Biochemistry Co., Ltd.
Nanjing Hospital & Homecare Imp. & Exp. Co., Ltd.
Shenzhen Yidatai Industrial Development Co., Ltd.
Changsha Sinocare Corporation
Pulsatom Healthcare Pvt Ltd
[Studien Infos ausblenden]

TABLE OF CONTENTS

1 Table of contents 3
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction and Overview 7
2.1 GlobalData Research Guidance 7
3 Disease Overview: Diabetes 8
3.1 Type I Diabetes 8
3.1.1 Introduction 8
3.1.2 Etiology, Disease Symptoms and Risk Factors 8
3.1.3 Pathophysiology 8
3.1.4 Epidemiology 9
3.1.5 Device Based Disease Treatment and Management: Insulin Delivery 10
3.2 Type 2 Diabetes 11
3.2.1 Introduction 11
3.2.2 Etiology, Disease Symptoms and Risk Factors 11
3.2.3 Pathophysiology 12
3.2.4 Epidemiology 13
3.2.5 Device Based Disease Treatment and Management: 13
4 Diabetes Care Devices, Emerging Markets: Market Characterization 15
4.1 Diabetes Care Devices, Emerging Markets, Historic Revenues ($m), 2002 – 2009 15
4.2 Diabetes Care Devices, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 16
4.3 Diabetes Care Devices, Emerging Markets, Key Company Shares 17
4.4 Diabetes Care Devices, Emerging Markets, Key Market Trends 20
4.4.1 Increased Government Programs for Diabetes Care Awareness 20
4.4.2 Localization of Manufacturing of Diabetes Care Devices by Big Players 20
4.5 Diabetes Care Devices, Emerging Markets, Market Dynamics 21
4.5.1 Market Drivers 21
4.5.2 Market Restraints 21
5 Glucose Monitoring, Emerging Markets: Market Characterization 23
5.1 Glucose Monitoring Strips, Emerging Markets, Historic Revenues ($m), 2002 – 2009 23
5.2 Glucose Monitoring Strips, Emerging Markets, Forecast Revenue ($m), 2009 – 2016 24
5.3 Blood Glucose Meters, Emerging Markets, Historic Revenues ($m), 2002 – 2009 25
5.4 Blood Glucose Meters, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 26
5.5 Glucose Monitoring, Emerging Markets, Market Dynamics 27
5.5.1 Market Drivers 27
5.5.2 Market Restraints 27
5.6 Glucose Monitoring, Emerging Markets, Key Company Shares 28
5.6.1 Glucose Monitoring, China, Key Company Shares, 2009 28
5.6.2 Glucose Monitoring, India, Key Company Shares, 2009 29
5.6.3 Glucose Monitoring, Brazil, Key Company Shares 2009 30
6 Insulin Delivery, Emerging Markets: Market Characterization 31
6.1 Insulin Syringes, Emerging Markets, Historic Revenues ($m), 2002 – 2009 31
6.2 Insulin Syringes, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 32
6.3 Insulin Pens, Emerging Markets, Historic Revenues ($m), 2002 – 2009 33
6.4 Insulin Pens, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 34
6.5 Insulin Pumps, Emerging Markets, Historic Revenues ($m), 2002 – 2009 35
6.6 Insulin Pumps, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 36
6.7 Insulin Pump Accessories, Emerging Markets, Historic Revenues ($m), 2002 – 2009 37
6.8 Insulin Pump Accessories, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 38
6.9 Insulin Delivery, Emerging Markets, Market Dynamics 39
6.9.1 Market Drivers 39
6.9.2 Market Restraints 39
6.10 Insulin Delivery, Emerging Markets, Key Company Shares, 2009 40
6.10.1 Insulin Delivery, China, Key Company Shares, 2009 40
6.10.2 Insulin Delivery, India, Key Company Shares 2009 41
6.10.3 Insulin Delivery, Brazil, Key Company Shares 2009 42
7 Diabetes Care Devices, Emerging Markets: Key Market Participants 43
7.1 Glucose Monitoring Devices Market 43
7.2 Insulin Delivery Devices Market 43
7.3 Company Profiles 43
7.3.1 F. Hoffmann-La Roche Ltd 43
7.3.2 LifeScan (Johnson & Johnson) 44
7.3.3 Bayer Healthcare 44
7.3.4 Abbott Laboratories 44
7.3.5 Becton, Dickinson and Company 45
7.3.6 Medtronic 45
7.3.7 Novo Nordisk 46
7.3.8 Other Companies 46
8 Appendix 47
8.1 Acronyms 47
8.2 Sources 47
8.3 Database 48
8.4 Research Methodology 48
8.5 Secondary Research 49
8.6 Primary Research 49
8.7 Models 50
8.8 Forecasts 50
8.9 Expert Panels 50
8.10 GlobalData Consulting 51
8.11 Contact Us 51
8.12 Disclaimer 51
[Inhaltsverzeichnis ausblenden]

LIST OF TABLES

1.1 List of Tables
Table 1: Incidence: New Cases of Type 1 Diabetes in Children (under 14 years) 2010 9
Table 2: Epidemiology: Percent of with Diabetes (20-79 years), 2010 (national) 13
Table 3: Diabetes Care Devices, Emerging Markets, Historic Revenues ($m), 2002 – 2009 15
Table 4: Diabetes Care Devices, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 16
Table 5: Diabetes Care Devices, China, Key Company Revenue ($m), 2009 17
Table 6: Diabetes Care Devices, India, Key Company Revenue ($m), 2009 18
Table 7: Diabetes Care Devices, Brazil, Key Company Revenue ($m), 2009 19
Table 8: Glucose Monitoring Strips, Emerging Markets, Historic Revenues ($m), 2002 – 2009 23
Table 9: Glucose Monitoring Strips, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 24
Table 10: Blood Glucose Meters, Emerging Markets, Historic Revenues ($m), 2002 – 2009 25
Table 11: Blood Glucose Meters, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 26
Table 12: Glucose Monitoring, China, Key Company Revenue ($m), 2009 28
Table 13: Glucose Monitoring, India, Key Company Revenue ($m), 2009 29
Table 14: Glucose Monitoring, Brazil, Key Company Revenue ($m), 2009 30
Table 15: Insulin Syringes, Emerging Markets, Historic Revenues ($m), 2002 – 2009 31
Table 16: Insulin Syringes, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 32
Table 17: Insulin Pens, Emerging Markets, Historic Revenues ($m), 2002 – 2009 33
Table 18: Insulin Pens, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 34
Table 19: Insulin Pumps, Emerging Markets, Historic Revenues ($m), 2002 – 2009 35
Table 20: Insulin Pumps, Emerging Markets, Forecasts Revenues ($m), 2009 – 2016 36
Table 21: Insulin Pump Accessories, Emerging Markets, Historic Revenues ($m), 2002 – 2009 37
Table 22: Insulin Pump Accessories, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 38
Table 23: Insulin Delivery, China, Key Company Revenue ($m), 2009 40
Table 24: Insulin Delivery, India, Key Company Revenue ($m), 2009 41
Table 25: Insulin Delivery, Brazil, Key Company Revenue ($m), 2009 42
Table 26: F Hoffman-La Roche, Key Marketed Products, Emerging Markets, 2010 43
Table 27: Johnson & Johnson, Key Marketed Products, Emerging Markets, 2010 44
Table 28: Bayer Healthcare, Key Marketed Products, Emerging Markets, 2010 44
Table 29: Abbott Laboratories, Key Marketed Products, Emerging Markets, 2010 44
Table 30: Becton Dickinson & Company, Key Marketed Products, Emerging Markets, 2010 45
Table 31: Medtronic, Key Marketed Products, Emerging Markets, 2010 45
Table 32: NovoNordisk, Key Marketed Products, Emerging Markets, 2010 46
Table 33: Local Diabetes Care Device Companies in China and India 46
LIST OF FIGURES

1.2 List of Figures
Figure 1: Incidence: New Cases of Type 1 Diabetes in Children (under 14 years) 2010 9
Figure 2: Epidemiology: Percent of with Diabetes (20-79 years), 2010 (national) 13
Figure 3: Diabetes Care Devices, Emerging Markets, Historic Revenues ($m), 2002 – 2009 15
Figure 4: Diabetes Care Devices, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 16
Figure 5: Diabetes Care Devices, China, Key Company Shares, 2009 17
Figure 6: Diabetes Care Devices, India, Key Company Shares, 2009 18
Figure 7: Diabetes Care Devices, Brazil, Key Company Shares, 2009 19
Figure 8: Glucose Monitoring Strips, Emerging Markets, Historic Revenues ($m), 2002 – 2009 23
Figure 9: Glucose Monitoring Strips, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 24
Figure 10: Blood Glucose Meters, Emerging Markets, Historic Revenues ($m), 2002 – 2009 25
Figure 11: Blood Glucose Meters, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 26
Figure 12: Glucose Monitoring, China, Key Company Shares, 2009 28
Figure 13: Glucose Monitoring, India, Key Company Shares, 2009 29
Figure 14: Glucose Monitoring, Brazil, Key Company Shares, 2009 30
Figure 15: Insulin Syringes, Emerging Markets, Historic Revenues ($m), 2002 – 2009 31
Figure 16: Insulin Syringes, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 32
Figure 17: Insulin Pens, Emerging Markets, Historic Revenues ($m), 2002 – 2009 33
Figure 18: Insulin Pens, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 34
Figure 19: Insulin Pumps, Emerging Markets, Historic Revenues ($m), 2002 – 2009 35
Figure 20: Insulin Pumps, Emerging Markets, Forecasts Revenues ($m), 2009 – 2016 36
Figure 21: Insulin Pump Accessories, Emerging Markets, Historic Revenues ($m), 2002 – 2009 37
Figure 22: Insulin Pump Accessories, Emerging Markets, Forecast Revenues ($m), 2009 – 2016 38
Figure 23: Insulin Delivery, China, Key Company Shares, 2009 40
Figure 24: Insulin Delivery, India, Key Company Shares, 2009 41
Figure 25: Insulin Delivery, Brazil, Key Company Shares, 2009 42
Figure 26: GlobalData Methodology 49
[Tabellenverzeichnis ausblenden]